Gene Editing: The Dual-use Conundrum
By Janet Phelan,
New Eastern Outlook
| 07. 11. 2016
Dual-use may be best understood by considering the functions of a knife. Used against an enemy, a knife can be deadly. In the hands of a skilled surgeon, a knife may be life-saving, removing a gangrenous appendage or excising a cancerous mass.
Wikipedia defines dual-use this way: “In politics and diplomacy, dual-use is technology that can be used for both peaceful and military aims. More generally speaking, dual-use can also refer to any technology which can satisfy more than one goal at any given time.”
Behind the debate over the Iran nuclear deal lurked the dual-use issue. On the one hand, there were those claiming that Iran had every right to develop nuclear power in pursuit of peaceful aims. In the other camp were those who maintained that possession of nuclear technology was a path towards developing nuclear weapons, and in the hands of a regime hostile to America’s purported friend and ally, Israel, was too dangerous to be allowed to manifest. Dual-use has implications reaching beyond nuclear science. Those watching the development of what is termed “biodefense” are uncomfortably...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...